AzTrials
AzTrials

Mallampati Score, Difficult Intubation, VideolaryngoscopeNCT03407898

The Effect of Different Videolaryngoscopes on Intubation Success in Difficult Airway Patients

An observational study of Mallampati Score, Difficult Intubation, Videolaryngoscope, run by Ankara University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Mallampati score > 3 generally indicate difficult airway and difficult intubation. Most anesthesiologist usually use this score system to predict difficult airway management. Different laryngoscopes may be useful in management of difficult airway. Read more about this study

Who is it for?
Ages 18 to 65 years
What is being tested?
intubation time
How many people
130 participants
Where
1 siteTurkey (Türkiye)
Study dates
2 May 2018to 1 Nov 2018
How long will I take part?
1 Day
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: patients who has mallampati score >3

Who may be able to join

  • mallampati score >3

Who cannot join

  • patient refusal

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Cigdem Yildirimguclu

    Ankara, 06550

Other trials in Turkey (Türkiye)

About this study

Mallampati score > 3 generally indicate difficult airway and difficult intubation. Most anesthesiologist usually use this score system to predict difficult airway management. Different laryngoscopes may be useful in management of difficult airway. This study designed to compare different videolaryngoscopes in intubation success in patient of Mallampati score>3.

Being tested
intubation time

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • intubation timeOther

    Also called intubation attempt

    intubation attempt number and intubation time

Study groups in NCT03407898
Study groupRoleWhat they receive
C-mac D blade used for intubationNot described
Receives: Other: intubation time
mcgrath X blade used for intubationNot described
Receives: Other: intubation time

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. intubation time

    Measured: 60 seconds

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Jan 2018
  2. Study start2 May 2018
  3. Primary completion1 Sep 2018
  4. Study completion1 Nov 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case crossover
Time perspective
Prospective
Enrolment
130 participants (actual)
Target duration
1 Day
IDs, dates and publications
ClinicalTrials.gov ID
NCT03407898
Sponsor's protocol ID
20-1006-16
Status last verified
Feb 2020
First submitted
17 Jan 2018
Last updated
28 Feb 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Mallampati Score, Difficult Intubation, Videolaryngoscope, run by Ankara University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 28 Feb 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

intubation time (time frame: 60 seconds). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Feb 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in